Peter Laird of the Keck School of Medicine of USC developed MethyLight technology, which is employed in Epigenomics AG’s proColon screening test that provides early detection of colon cancer with a simple blood draw. Epigenomics is also currently developing similar tests based on this technology for the early detection of prostate and lung cancer.